Table V.
Dose estimates obtained by three participating laboratories (L1, L2, and L6) based on dicentric analysis in G0-lymphocyte PCCs, using Centromere-Telomere staining with peptide nucleic acid (PNA) probes, for both samples Re5 (0.85 Gy) and Re6 (2.7 Gy).
| Code | Whole body dose estimate and 95% confidence limits | Participating Laboratory | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 20 cells | 30 cells | 50 cells | ||||||||
| dose (Gy) | LCL | UCL | dose (Gy) | LCL | UCL | dose (Gy) | LCL | UCL | ||
| Re5a | 0.78 | 0.04 | 1.96 | 0.98 | 0.30 | 1.89 | 0.77 | 0.26 | 1.46 | L1 |
| Re5a | 1.8 | 0.95 | 2.78 | 1.5 | 0.86 | 2.34 | 1.5 | 0.95 | 2.08 | L2 |
| Re5a | 0.7 | 0.5 | 0.9 | 0.9 | 0.7 | 1.2 | 1 | 0.7 | 1.2 | L6 |
| Re5b | 1.3 | 1.1 | 1.7 | 1.4 | 1.1 | 1.8 | 1 | 0.8 | 1.3 | L6 |
| Re6a | 3.66 | 2.72 | 4.70 | 3.12 | 2.36 | 3.96 | 3.29 | 2.70 | 3.93 | L1 |
| Re6a | 3.3 | 2.48 | 4.29 | 2.9 | 2.28 | 3.74 | 2.7 | 2.17 | 3.29 | L2 |
| Re6a | 2.4 | 1.9 | 2.9 | 2.3 | 1.8 | 2.7 | 2.3 | 1.8 | 2.7 | L6 |
| Re6b | 2.8 | 2.2 | 3.3 | 2.5 | 2 | 3 | 2.2 | 1.7 | 2.6 | L6 |